The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOrcadian Engy Regulatory News (ORCA)

Share Price Information for Orcadian Engy (ORCA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.875
Bid: 10.50
Ask: 11.25
Change: 0.00 (0.00%)
Spread: 0.75 (7.143%)
Open: 10.875
High: 10.875
Low: 10.875
Prev. Close: 10.875
ORCA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AJ Bell Investor Presentation

3 Sep 2021 07:00

RNS Number : 6131K
Orcadian Energy PLC
03 September 2021
 

 

 

 

 

3 September 2021

Orcadian Energy plc

("Orcadian Energy", "Orcadian" or the "Company")

AJ Bell Investor Presentation

 

Orcadian Energy (AIM: ORCA), the North Sea focused, oil and gas development company, is pleased to announce that Steve Brown, CEO and Alan Hume, CFO will be presenting at the AJ Bell investor Webinar on Wednesday 8th September 2021. The Webinar starts at 6pm with the Company presenting live at 7.20pm.

Should shareholders or potential investors wish to register to attend the virtual event, which is available free of charge, please follow this link:

https://www.sharesmagazine.co.uk/events/event/shares-investor-webinar-080921

A copy of the presentation given to the webinar will be available to view post the event on the Company's website.

 

For further information on the Company please visit the Company's website: https://orcadian.energy

 

 

Contact:

 

Orcadian Energy plc

+ 44 20 7920 3150

Steve Brown, CEO

Alan Hume, CFO

WH Ireland (Nomad and Sole Broker)

+44 20 7220 1666

Harry Ansell / Fraser Marshall (Corporate Broking)

 

Katy Mitchell / James Sinclair-Ford / Lydia Zychowska

(Nomad)

Tavistock (PR)

+ 44 20 7920 3150

Nick Elwes / Simon Hudson / Matthew Taylor

orcadian@tavistock.co.uk

 

 

About Orcadian Energy

Orcadian Energy (CNS) Ltd ("CNS"), Orcadian's operating subsidiary, was founded in 2014 and is the sole licensee of P2244, which contains 78.8 MMbbl of 2P reserves in the Pilot discovery, and of P2320 and P2482, which contain a further 77.8 MMbbl of 2C contingent resources in the Elke, Narwhal and Blakeney discoveries (as audited by Sproule, see the CPR in the Company's Admission Document for more details). Within these licences there are also 191 MMbbl of unrisked prospective resources. These licences are in blocks 21/27, 21/28, 28/2 and 28/3, and lie 150 kms due East of Aberdeen. The Company also has a 50% working interest in P2516, which contains the Fynn discoveries. P2516 is administered by the Parkmead Group and covers blocks 14/20g and 15/16g, which lie midway between the Piper and Claymore fields, 180 kms due East of Wick.

Pilot, which is the largest oilfield in Orcadian's portfolio was discovered by Fina in 1989 and has been well appraised. In total five wells and two sidetracks were drilled on Pilot, including a relatively short horizontal well which produced over 1,800 bbls/day on test. Orcadian's proposed development plan for Pilot is based upon a Floating Production Storage and Offloading vessel, with over thirty wells to be drilled by a Jack-up rig through a pair of well head platforms and will include a floating wind turbine to provide much of the energy used in the production process. Emissions per barrel produced are expected to be about an eighth of the 2018 North Sea average and to lie in the lowest 5% of global oil production.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUPUAGBUPGGBP
Date   Source Headline
8th Apr 20242:46 pmRNSHolding(s) in Company
8th Apr 20242:44 pmRNSHolding(s) in Company
4th Apr 202411:03 amRNSInvestor Presentation via Investor Meet Company
2nd Apr 20247:00 amRNSCompletion of Pilot Farm-out
18th Mar 20247:00 amRNSChange of Nominated Adviser and Broker
14th Mar 202411:04 amRNSAmendment to Facility Agreement
27th Feb 20247:00 amRNSResults for the half year ended 31 December 2023
1st Feb 20247:00 amRNS33rd Licensing Round Offer of Awards
17th Jan 202412:45 pmRNSResult of General Meeting & Annual General Meeting
15th Jan 20242:56 pmRNSHolding(s) in Company
12th Jan 202410:57 amRNSHolding(s) in Company
20th Dec 20237:00 amRNSCirc re. Disposal & Notice of GM
18th Dec 20237:15 amRNS£500,000 equity financing & TVR
18th Dec 20237:02 amRNS33rd Licensing Round Update
18th Dec 20237:00 amRNSFinal Results
8th Dec 20237:00 amRNSInvestor Presentation via Investor Meet Company
7th Dec 202311:12 amRNSPilot Farm-out Deal and Partnership with Ping
1st Dec 20237:00 amRNSPilot Farm-out Update
7th Nov 20237:28 amRNSAnnual Licensing Rounds
25th Oct 20237:00 amRNSTwo Year Pilot Licence Extension
23rd Oct 20237:00 amRNSLock-in agreement
2nd Oct 20237:00 amRNS£350,000 equity financing & Update of 33rd Round
21st Sep 202312:37 pmRNSPDMR Update
19th Sep 20237:00 amRNSInvestor Presentation via Investor Meet Company
18th Sep 20237:00 amRNSProposed Farm-in to the Pilot Project
13th Sep 20231:32 pmRNSAmendment to Facility Agreement
23rd Aug 20237:00 amRNSAmendment to Facility Agreement
2nd Aug 202312:06 pmRNSShare Price Movement Update
1st Aug 20237:00 amRNSHolding(s) in Company
15th May 20237:00 amRNSDetermination of Licence P2320
30th Mar 20237:00 amRNSResults for the half year ended 31 December 2022
22nd Mar 20239:05 amRNSSecond Price Monitoring Extn
22nd Mar 20239:00 amRNSPrice Monitoring Extension
9th Mar 20234:35 pmRNSPrice Monitoring Extension
2nd Feb 202311:05 amRNSSecond Price Monitoring Extn
2nd Feb 202311:00 amRNSPrice Monitoring Extension
2nd Feb 20239:05 amRNSSecond Price Monitoring Extn
2nd Feb 20239:00 amRNSPrice Monitoring Extension
1st Feb 20234:40 pmRNSSecond Price Monitoring Extn
1st Feb 20234:35 pmRNSPrice Monitoring Extension
1st Feb 20232:05 pmRNSSecond Price Monitoring Extn
1st Feb 20232:00 pmRNSPrice Monitoring Extension
1st Feb 202311:05 amRNSSecond Price Monitoring Extn
1st Feb 202311:00 amRNSPrice Monitoring Extension
1st Feb 202310:01 amRNSResult of Placing
1st Feb 20237:00 amRNSProposed Placing to raise approximately £0.5m
19th Jan 20237:00 amRNS33rd Offshore Licensing Round
17th Jan 20231:05 pmRNSResult of Annual General Meeting
11th Jan 20237:00 amRNSProposed Disposal of Crinan and Dandy discoveries
10th Jan 20237:00 amRNSPilot Technical Resource Upgrade

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.